ABBV vs. MRK
Compare and contrast key facts about AbbVie Inc. (ABBV) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABBV or MRK.
Correlation
The correlation between ABBV and MRK is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ABBV vs. MRK - Performance Comparison
Loading data...
Key characteristics
ABBV:
0.82
MRK:
-1.35
ABBV:
1.18
MRK:
-1.84
ABBV:
1.18
MRK:
0.75
ABBV:
1.10
MRK:
-0.87
ABBV:
2.67
MRK:
-1.58
ABBV:
8.52%
MRK:
22.81%
ABBV:
27.67%
MRK:
27.04%
ABBV:
-45.09%
MRK:
-68.62%
ABBV:
-11.46%
MRK:
-38.09%
Fundamentals
ABBV:
$326.55B
MRK:
$190.76B
ABBV:
$2.34
MRK:
$6.88
ABBV:
78.89
MRK:
11.04
ABBV:
0.39
MRK:
0.70
ABBV:
5.69
MRK:
2.98
ABBV:
229.63
MRK:
3.95
ABBV:
$57.37B
MRK:
$63.92B
ABBV:
$44.44B
MRK:
$51.75B
ABBV:
$16.33B
MRK:
$27.30B
Returns By Period
In the year-to-date period, ABBV achieves a 8.97% return, which is significantly higher than MRK's -18.45% return. Over the past 10 years, ABBV has outperformed MRK with an annualized return of 15.94%, while MRK has yielded a comparatively lower 6.65% annualized return.
ABBV
8.97%
9.58%
11.01%
22.54%
21.38%
15.94%
MRK
-18.45%
1.58%
-18.82%
-36.33%
4.78%
6.65%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABBV vs. MRK — Risk-Adjusted Performance Rank
ABBV
MRK
ABBV vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ABBV vs. MRK - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.36%, less than MRK's 3.93% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.36% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
MRK Merck & Co., Inc. | 3.93% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
ABBV vs. MRK - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum MRK drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for ABBV and MRK. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ABBV vs. MRK - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 9.61%, while Merck & Co., Inc. (MRK) has a volatility of 10.45%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ABBV vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. MRK - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.